ValeVita Menopause Capsule
Natural health product licensed in Canada
- Other names
- ValeVita Meno-Care Capsule
- Licence holder
- Vitalita Life Technology Inc.
- NPN or DIN-HM
- 80073675
- Status
- Active licence
- Licence date
- 9 November 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Actaea racemosa L.: Seuls les extraits aqueux et hydro-alcooliques de titre faible (30 %) sont admis. La portion journalière recommandée ne doit pas conduire à une ingestion de glycosides de triterpène (calculés comme 27-déoxyactéine) supérieure à 3 mg.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Folate Source : Acide folique | 33.33 microgrammes | Not calculated |
| Acide L-ascorbique Source : Acide ascorbique | 20 milligramme | Not calculated |
| L-théanine Source : L-Théanine | 15 milligramme | Not calculated |
| Acide gamma-aminobutyrique Source : Acide 4-aminobutanoïque | 35 milligramme | Not calculated |
| bêta-carotène Source : bêta-carotène Potency : 1,666.67 UI | 1,000 microgrammes | Not calculated |
| Zingiber officinale Source : Zingiber officinale - Rhizome Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 75 mg Potency : 0.75 mg Total gingerols | 15 milligramme | Not calculated |
| Glycyrrhiza glabra Source : Glycyrrhiza glabra - Racine et stolon Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 150 mg | 15 milligramme | Not calculated |
| Vitamine D Source : Cholécalciférol Potency : 333.33 UI | 8.33 microgrammes | Not calculated |
| Extrait d'isoflavone de soja Source : Extrait d'isoflavone de soja Potency : 15 mg Isoflavones | 37.5 milligramme | Not calculated |
| Vitamine E Source : Acétate de dl-alpha tocophéryle Potency : 10 UI | 4.6 mg AT | Not calculated |
| Vitamin K2 Source : Ménaquinone 7 | 10 microgrammes | Not calculated |
| Magnésium Source : Oxyde de magnésium | 20 milligramme | 60,000 µg |
| Calcium Source : Carbonate de calcium | 60 milligramme | 180,000 µg |
| Trigonella foenum-graecum Source : Trigonella foenum-graecum - Graine Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 800 mg | 40 milligramme | Not calculated |
| Actaea racemosa Source : Racine et rhizome Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 500 mg Potency : 1.25 mg Triterpene glycosides | 50 milligramme | Not calculated |
| Extrait d'isoflavones de trèfle rouge Source : Trifolium pratense- Fleur Potency : 3.2 mg Isoflavones | 40 milligramme | Not calculated |
| Angelica sinensis Source : Angelica sinensis - Racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 140 mg | 35 milligramme | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Microcrystalline cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
May reduce severe and frequent menopausal symptoms (such as hot flashes/flushes and/or night sweats). Helps to reduce bone mineral density loss in post-menopausal women when used in conjunction with adequate amounts of calcium and vitamin D.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80073675
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.